Atlas Trials

A Study of the Gut Microbiome in Hormone Receptor-positive HER2-negative Breast Cancer Treated With CDK4/6 Inhibitors

Clinical trial NCT06171360 · RECRUITING

Trial details

NCT number
NCT06171360
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Status
RECRUITING
Study type
OBSERVATIONAL
Breast Cancer
Start date
2022-11-15
Primary completion
2026-11-15
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.